Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
PALLITE manufactures environmentally-friendly products made from 100% recyclable paper honeycomb board which contains over 75% recycled content. It asserts that these products can be used to move, protect, & store goods. The company has partnered with companies like DS Smith, The Hut Group, and Rockwell Automation to further its mission of making sustainable packaging and products. It witnessed sales of £229,000 at a gross margin of 45% and a record gross profit of £103,000 in September 2020. PALLITE will soon launch its 'EcoLITE' range of recycled and insulative packaging to replace polystyrene and foam amidst other upcoming innovations. The company will use the investment to grow its business across different verticals and become a sustainable brand.
days to go:
Expired
investment:
£1,311,835
Doc2UK is a specialist UK medical recruitment and candidate support platform. Based in London, the platform places qualified doctors in the National Health Scheme (NHS) roles around the United Kingdom. The British Medical Association (2018) reported that patient care is at risk due to a critical shortage of doctors across multiple medical disciplines. At present, the UK only has 24 medical schools to fill this gap, whilst India, in comparison, has 468 medical schools, with 68,000 doctors graduating each year. Moreover, uncertainty about the status of EU nationals after Brexit, changes to immigration policies, and the impact of changing language testing requirements for international nurses have made this crisis worse. This situation necessitates recruiting doctors from overseas an important endeavour. This is where Doc2UK aims to become a key player and ensure that lack of medical personnel doesn't disrupt any medical services. The company is seeking an investment of up to £300,000 which will be used to develop the platform with more features, expand the team, marketing and sales.
days to go:
Expired
investment:
Withheld
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go:
Expired
investment:
£136,827
The British Snack Co makes quirky and original British snacks. The company's award-winning flavours and unique ranges of craft popcorn, crisps, and pork snacks have sold over 8 million bags to date. It aims to be a contender in the £3.2 billion UK snacks market. The company's products are stocked across major retailers like Waitrose, Ocado's, Morrisons, Borough Box, and Amazon, to name a few. Its craft pork scratching product, Awfully Posh, was the first pork snack ever to win a Great Taste Award. The company has been working with buyers in the hospitality industry to create joint marketing plans for after lockdown to rapidly grow its Out Of Home (OOH) sales. It will use 50% of the investment to grow its staff, 37.5% towards trade marketing, and 12.5% for New Product Development (NPD).
days to go:
Expired
investment:
£382,495
Hagley West is an online watch company co-owned by cricketing legend, Chris Gayle. The brand has more than 50,000 followers on Social Media and has already sold its products in 39 different countries. To eliminate high barriers constructed by big brand markups and sales agents, Hagley West has developed a strategy to deliver direct to the consumer. Hagley West aims at increasing its presence to billions of global cricket fans with growth plans focused in the Asian market. With the proceeds, the company will accelerate its core business, develop new ranges, and expand into new markets.
days to go:
Expired
investment:
£353,540
